Catalio Capital Management, LP has filed its 13F form on November 14, 2025 for Q3 2025 where it was disclosed a total value porftolio of $541 Billion distributed in 38 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Eli Lilly & CO with a value of $43.8B, Abb Vie Inc. with a value of $35.9B, Bridge Bio Pharma, Inc. with a value of $32.3B, Intuitive Surgical Inc with a value of $31.9B, and Ascendis Pharma A/S with a value of $28.8B.
Examining the 13F form we can see an increase of $64B in the current position value, from $477B to 541B.
Catalio Capital Management, LP is based out at New York, NY
Below you can find more details about Catalio Capital Management, LP portfolio as well as his latest detailed transactions.
